证券代码：688603 证券简称：天承科技 公告编号：2025-012 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 一、利润分配方案内容 （一）利润分配方案的具体内容 1、公司拟向全体股东按每 10 股派发现金红利 3 元（含税）。截至 2024 年 3 月 28 日，公司总股本为 83,957,192 股，扣除公司回购专用证券账户中股份数 758,556 股 后 的 股 本 数 为 83,198,636 股 ， 以 此 计 算 合 计 拟 派 发 现 金 红 利 24,959,591 元（含税）。本年度公司现金分红总额为 24,959,591 元（含税）；本 年度以现金为对价，采用集中竞价方式已实施的股份回购金额为 37,773,122.82 每股分配比例：每股派发现金红利人民币 0.30 元（含税），以资本公积金每 10 股转增 4.9 股，不送红股。 本次利润分配以实施权益分派股权登记日登记的总股本扣减公司回购专用 证券账户中股份为基数分配利润及使用资本公积金转增股本，具体日期将 在权益分派实施公 ...

一、主要会计数据和财务指标 | 报告期指标 | 2024年年报 | 2023年年报 | 本年比上年增减(%) | 2022年年报 | | --- | --- | --- | --- | --- | | 基本每股收益（元） | 0.8900 | 0.7900 | 12.66 | 1.2600 | | 每股净资产（元） | 0 | 18.87 | -100 | 7.49 | | 每股公积金(元) | 9.78 | 14.44 | -32.27 | 3.27 | | 每股未分配利润(元) | 2.88 | 3.22 | -10.56 | 2.96 | | 每股经营现金流(元) | - | - | - | - | | 营业收入(亿元) | 3.81 | 3.39 | 12.39 | 3.74 | | 净利润(亿元) | 0.75 | 0.59 | 27.12 | 0.55 | | 净资产收益率(%) | 6.80 | 8.23 | -17.38 | 18.43 | | 名称 | 持有数量(万股) | 占总股本 | 增减情 | | --- | --- | --- | --- | | | | 比例(%) | 况(万股) ...

民生证券股份有限公司关于广东天承科技股份有限公司 首次公开发行部分限售股上市流通的核查意见 民生证券股份有限公司(以下简称"保荐机构"或"民生证券")作为广东天承 科技股份有限公司(以下简称"公司"或"天承科技")首次公开发行股票并在科创 板上市的保荐机构,根据《证券发行上市保荐业务管理办法》《上海证券交易所 科创板股票上市规则》等相关法律法规的规定,对天承科技首次公开发行部分限 售股上市流通事项进行了核查,核查具体情况如下: 一、本次上市流通的限售股类型 根据中国证券监督管理委员会于 2023年4月18 日出具的《关于同意广东天 承科技股份有限公司首次公开发行股票注册的批复》(证监许可〔2023〕849 号), 公司首次公开发行人民币普通股（A 股）14,534,232 股，并于 2023 年 7 月 10 日 在上海证券交易所科创板上市。公司首次公开发行后,总股本为58,136,926 股, 其中有限售条件流通股为 46,120,608 股，无限售条件流通股为 12,016,318 股。 2024 年 1 月 3 目公司发布《广东天承科技股份有限公司首次公开发行网下 配售限售股上市流通公告》（公告编号:2 ...

证券代码：688603 证券简称：天承科技 公告编号：2025-009 广东天承科技股份有限公司 首次公开发行部分限售股上市公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 本次股票上市类型为首发限售股份；股票认购方式为网下，上市股数为 820,014 股。 本次股票上市流通总数为 820,014 股。 本次股票上市流通日期为 2025 年 3 月 28 日。 一、本次上市流通的限售股类型 根据中国证券监督管理委员会于 2023 年 4 月 18 日出具的《关于同意广东天 承科技股份有限公司首次公开发行股票注册的批复》（证监许可〔2023〕849 号）， 公司首次公开发行人民币普通股（A 股）14,534,232 股，并于 2023 年 7 月 10 日 在上海证券交易所科创板上市。公司首次公开发行后，总股本为 58,136,926 股， 其中有限售条件流通股为 46,120,608 股，无限售条件流通股为 12,016,318 股。 2024 年 1 月 3 日公司发布《广东天承科技股份有限公司首次公 ...

Financial Performance - The total operating revenue for 2024 reached RMB 380.67 million, an increase of 12.32% compared to the previous year[4] - The net profit attributable to the parent company was RMB 76.84 million, reflecting a year-on-year growth of 31.19%[4] - The operating profit for the period was RMB 89.35 million, up 31.65% from the same period last year[11] - The net profit after deducting non-recurring gains and losses was RMB 64.27 million, a 17.09% increase year-on-year[4] - The basic earnings per share rose to RMB 0.92, a 16.46% increase year-on-year[4] Assets and Equity - The total assets at the end of the reporting period amounted to RMB 1,242.60 million, a growth of 6.14% from the beginning of the period[9] - The equity attributable to the parent company was RMB 1,123.97 million, increasing by 2.45% compared to the start of the period[9] - The company’s total share capital increased by 44.41% to 83.96 million shares due to capital reserve conversion[12] Operational Efficiency - The company improved operational quality through refined cash management strategies, enhancing overall efficiency[10] - The weighted average return on net assets decreased to 6.99%, down 1.24 percentage points from the previous year[4]

证券代码：688603 证券简称：天承科技 公告编号：2025-007 广东天承科技股份有限公司 关于股份回购实施结果暨股份变动的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： | 回购方案首次披露日 | | | 2024/1/25，由公司实际控制人、董事长、总经理 | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | 童茂军先生提议 | | | | | | | | | | 回购方案实施期限 | | | | | | | | | | | 预计回购金额 | 3,000 万元~5,000 万元 | | | | | | | | | | | 74.66 元/股） | | | | | | | | | | 回购用途 | □减少注册资本 | | | | | | | | | | | √用于员工持股计划或股权激励 | | | | | | | | | | | □用于转换公司可转债 | | | | | | | | | | | ...

2024 年 1 月 31 日，公司召开第二届董事会第六次会议审议通过了《关于以 集中竞价交易方式回购公司股份方案的议案》，同意公司以集中竞价交易方式回 购公司股份，并在未来适宜时机全部用于员工持股计划或股权激励。回购股份的 资金总额不低于人民币 3,000 万元（含），不高于人民币 5,000 万元（含）；资 金来源为自有资金；回购的价格不超过人民币 75 元/股；回购的期限为自公司董 事会审议通过本次回购方案之日起 12 个月内。具体内容详见公司分别于 2024 年 2 月 1 日和 2024 年 2 月 6 日在上海证券交易所网站（www.sse.com.cn）披露 的《关于以集中竞价交易方式回购公司股份暨公司"提质增效重回报"行动方案 的公告》（公告编号：2024-003）《关于以集中竞价交易方式回购公司股份的回 购报告书》（公告编号：2024-005）。公司 2023 年年度权益分派实施后，公司 以集中竞价交易方式回购股份价格上限由不超过人民币 75 元/股调整为不超过人 1 证券代码：688603 证券简称：天承科技 公告编号：2025-005 广东天承科技股份有限公司关于 2024 年前三季度权 ...

Company and Industry Summary Company Overview - The company is focused on electronic chemical products, particularly in the integrated circuit sector, and aims to enhance its market presence through strategic partnerships and product development [3][21]. Key Industry Insights - The company has established deep collaborations with leading domestic storage and packaging testing companies, actively pushing for mass production with a target of achieving breakthroughs with 1-2 major clients within the year [4][5]. - The revenue and profit growth for 2025-2026 is expected to primarily come from the PCB sector, projected to grow by 30%-40% annually, and the high-end HDI segment, with ongoing efforts to secure international top-tier clients [4][7]. Strategic Partnerships and Collaborations - The company is working closely with major clients in the construction equipment sector, focusing on significant projects from Shanghai to Beijing, leveraging its platform and team capabilities [3]. - A new factory in Southeast Asia is under construction, having received orders exceeding ten million, with plans to establish production capacity near Bangkok to meet local supply demands [9]. Product Development and Market Position - The glass substrate business is currently leading in the domestic market, with a strategy to prioritize collaboration with the largest clients to secure market share while continuously improving technology and products [10][11]. - The semiconductor business has a revenue target of 20 million yuan for the current year, with a long-term goal of capturing 30% market share domestically within 3-4 years, translating to 100-200 million yuan in revenue [12]. Financial Projections and Goals - The PCB chemical business aims for revenue of 700-800 million yuan over the next two to three years [13]. - The semiconductor business is expected to maintain a gross margin above 90%, with potential adjustments as production scales up [14]. Research and Development Focus - The company is actively recruiting talent and developing cutting-edge technologies, including optoelectronic materials, while maintaining confidentiality on specific details [15]. - There is a focus on expanding core technologies into emerging fields such as robotics and AI, which are anticipated to drive PCB demand [16]. Capacity and Operational Efficiency - Current production is concentrated in Shanghai, with a year-on-year output growth of 40% in the first half of the year, and plans for further capacity expansion without immediate urgency to initiate projects in other locations [17][18]. Financial Health and Acquisition Strategy - The company has a healthy cash flow from its PCB chemical business, with 800 million yuan in cash reserves, exploring opportunities for external acquisitions to leverage its platform and funding advantages [19]. Future Development Strategy - The company is focusing on high-margin formulation materials, aiming to establish a leading position in the semiconductor sector while exploring related fields for gradual growth [20]. Conclusion - The company is positioned as a specialized player in the electronic chemical sector, with a strategic focus on partnerships, product innovation, and market expansion, while maintaining a strong financial foundation for future growth [21].

证券代码：688603 证券简称：天承科技 公告编号：2025-004 广东天承科技股份有限公司 第二届董事会第十五次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、董事会会议召开情况 广东天承科技股份有限公司（以下简称"公司"）第二届董事会第十五次会议 通知于 2025 年 1 月 9 日以邮件形式送达全体董事，本次会议于 2025 年 1 月 10 日 以现场结合通讯的方式召开。全体董事一致同意豁免本次董事会的通知时限。本次 会议由董事长童茂军先生召集并主持召开，会议应出席董事 6 人，实际出席董事 6 人，公司监事、高级管理人员列席会议。 本次会议的召集和召开程序符合《中华人民共和国公司法》《中华人民共和 国证券法》及《广东天承科技股份有限公司章程》（以下简称"《公司章程》"） 等有关规定，会议决议合法、有效。 二、董事会会议审议情况 经与会董事投票表决，审议通过了如下议案： （一）审议通过《关于对外投资设立控股子公司的议案》 基于公司整体的战略规划，为更好开展集成电路业务、提高整体竞争力并加 速融入上 ...

Core Points - The company plans to increase its share capital by converting capital reserves into shares, distributing 4.5 additional shares for every 10 shares held, without cash dividends [1] - The total share capital before the increase is 58,136,926 shares, and after the increase, it will rise to 83,957,192 shares [1] - The record date for the rights distribution is set for January 3, 2025, and the ex-rights date is January 6, 2025 [2][3] Group 1 - The company will adjust the total distribution amount and the total increase amount if there are changes in total share capital due to convertible bonds, share buybacks, or other corporate actions [1] - The reference price for the ex-rights will be calculated based on the formula: (previous closing price - cash dividend) / (1 + change in circulating shares ratio), with the cash dividend being zero [1] - The circulating shares change ratio is approximately 0.4441, leading to a specific calculation for the ex-rights reference price [1] Group 2 - The number of unrestricted shares to be listed is 9,137,712 shares, with the listing date also set for January 6, 2025 [3][4] - The company is implementing a differentiated distribution plan for the capital reserve conversion [3]